Skip to main content

Sequenom to Collaborate with Chinese University of Hong Kong on Prenatal Diagnostic Technology

NEW YORK, Aug. 10 (GenomeWeb News) - Sequenom said today that it has formed a research collaboration with the Chinese University of Hong Kong to develop prenatal diagnostic application's for Sequenom's MassArray platform.

 

The deal includes the placement of a MassARRAY Compact DNA analysis system at the department of chemical pathology of CUHK, and is designed to accelerate the introduction of non-invasive prenatal tests from the laboratory into the clinical diagnostic market, said Sequenom.

 

In July, Sequenom announced that a previous collaboration with CUHK had resulted in the development of a novel process to determine genetic mutations in circulating fetal nucleic acids in maternal plasma.

 

Specific terms of the company's arrangement with CUHK were not disclosed.

 

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.